MetaVia Inc. (MTVA) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of MetaVia Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MTVA
MetaVia Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
SNTI
Senti Biosciences, Inc.
$0.33HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
Total return — MTVA vs SNTI
growth of $100 · dividends reinvested · last 2yMTVA -94.5% (-76.5%/yr)SNTI -84.6% (-60.7%/yr)SNTI compounded faster over this window
MTVA SNTI
MTVA vs SNTI: by the numbers
- •SNTI is the larger company ($10M vs $10M market cap).
- •Both run net losses; MTVA's is the smaller (0.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | MTVA | SNTI |
|---|---|---|
| P/S ratio | N/A | 185.96 |
| P/B ratio | 1.41 | N/A |
Profitability
| Metric | MTVA | SNTI |
|---|---|---|
| Gross margin | 0.00% | -16431.82% |
| Operating margin | 0.00% | -289668.18% |
| Net margin | 0.00% | -90116.36% |
| ROE | -211.76% | N/A |
| ROIC | -215.61% | -227.67% |
Growth (annualized)
| Metric | MTVA | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | N/A | -67.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.